Mednax Inc (MD) - Total Assets

Latest as of March 2026: $2.07 Billion USD

Based on the latest financial reports, Mednax Inc (MD) holds total assets worth $2.07 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Mednax Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Mednax Inc - Total Assets Trend (1994–2025)

This chart illustrates how Mednax Inc's total assets have evolved over time, based on quarterly financial data. See MD total equity for net asset value and shareholders' equity analysis.

Mednax Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Mednax Inc's total assets of $2.07 Billion consist of 34.0% current assets and 66.0% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $375.24 Million 16.7%
Accounts Receivable $242.31 Million 10.8%
Inventory $0.00 0.0%
Property, Plant & Equipment $73.51 Million 3.3%
Intangible Assets $16.86 Million 0.8%
Goodwill $1.26 Billion 56.1%

Asset Composition Trend (1994–2025)

This chart illustrates how Mednax Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Mednax Inc (MD) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Mednax Inc's current assets represent 34.0% of total assets in 2025, a decrease from 84.7% in 1994.
  • Cash Position: Cash and equivalents constituted 16.7% of total assets in 2025, down from 36.5% in 1994.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 0.0% in 1994.
  • Asset Diversification: The largest asset category is goodwill at 56.1% of total assets.

Mednax Inc Competitors by Total Assets

Key competitors of Mednax Inc based on total assets are shown below.

Company Country Total Assets
Fresenius SE & Co. KGaA
XETRA:FRE
Germany €42.46 Billion
Top Choice Medical Investment Co Inc
SHG:600763
China CN¥6.24 Billion
PACS Group, Inc.
NYSE:PACS
USA $5.66 Billion
Pacific Smiles Group Ltd
AU:PSQ
Australia AU$163.53 Million
Pihlajalinna Oy
HE:PIHLIS
Finland €575.10 Million
ARRAIL GROUP LTD.
F:I1D
Germany €3.16 Billion
Ramsay Health Care Ltd
AU:RHC
Australia AU$21.70 Billion
Regis Healthcare Ltd
AU:REG
Australia AU$2.11 Billion

Mednax Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.33 1.81 2.14
Quick Ratio 1.33 1.81 2.09
Cash Ratio 0.00 0.37 0.96
Working Capital $144.40 Million $220.62 Million $401.21 Million

Mednax Inc - Advanced Valuation Insights

This section examines the relationship between Mednax Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.20
Latest Market Cap to Assets Ratio 0.88
Asset Growth Rate (YoY) 4.4%
Total Assets $2.25 Billion
Market Capitalization $1.98 Billion USD

Valuation Analysis

Near Book Valuation: The market values Mednax Inc's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Mednax Inc's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Mednax Inc (1994–2025)

The table below shows the annual total assets of Mednax Inc from 1994 to 2025.

Year Total Assets Change
2025-12-31 $2.25 Billion +4.37%
2024-12-31 $2.15 Billion -3.02%
2023-12-31 $2.22 Billion -5.45%
2022-12-31 $2.35 Billion -13.76%
2021-12-31 $2.72 Billion -18.68%
2020-12-31 $3.35 Billion -19.25%
2019-12-31 $4.15 Billion -30.14%
2018-12-31 $5.93 Billion +1.15%
2017-12-31 $5.87 Billion +9.89%
2016-12-31 $5.34 Billion +17.42%
2015-12-31 $4.55 Billion +26.00%
2014-12-31 $3.61 Billion +18.34%
2013-12-31 $3.05 Billion +10.87%
2012-12-31 $2.75 Billion +21.02%
2011-12-31 $2.27 Billion +11.53%
2010-12-31 $2.04 Billion +20.62%
2009-12-31 $1.69 Billion +12.86%
2008-12-31 $1.50 Billion +14.90%
2007-12-31 $1.30 Billion +14.77%
2006-12-31 $1.14 Billion +26.07%
2005-12-31 $900.40 Million +14.14%
2004-12-31 $788.89 Million +9.94%
2003-12-31 $717.59 Million +10.62%
2002-12-31 $648.68 Million +13.19%
2001-12-31 $573.10 Million +76.48%
2000-12-31 $324.73 Million -3.01%
1999-12-31 $334.80 Million +23.68%
1998-12-31 $270.70 Million +37.55%
1997-12-31 $196.80 Million +23.77%
1996-12-31 $159.00 Million +127.47%
1995-12-31 $69.90 Million +244.33%
1994-12-31 $20.30 Million --

About Mednax Inc

NYSE:MD USA Medical Care Facilities
Market Cap
$2.15 Billion
Market Cap Rank
#6119 Global
#1947 in USA
Share Price
$26.14
Change (1 day)
+1.67%
52-Week Range
$11.98 - $27.39
All Time High
$82.61
About

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more